These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3735530)

  • 21. Treatment of superficial bladder cancer with intravesical mitomycin C: analysis of immediate and long-term response in 70 patients.
    Soloway MS
    J Urol; 1985 Dec; 134(6):1107-9. PubMed ID: 3932684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carcinoma in situ associated with superficial bladder tumor.
    Solsona E; Iborra I; Ricós JV; Monrós JL; Dumont R; Casanova J; Calabuig C
    Eur Urol; 1991; 19(2):93-6. PubMed ID: 1902418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Can topical chemoprevention modify the rate of recurrence and progression of superficial bladder cancer?].
    Egghart G; Steegmüller O; Wenderoth U; Hautmann R
    Urologe A; 1988 May; 27(3):147-51. PubMed ID: 3136576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Stage P-1 primary neoplasia of the bladder. Critical evaluation of results obtained with the use of adriamycin and mitomycin C in the prevention of recurrences].
    Liberti M; Tenaglia R; De Berardinis E; Gentile V
    Minerva Med; 1984 Feb; 75(8):391-4. PubMed ID: 6424059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravesical thiotepa and mitomycin C treatment immediately after transurethral resection and later for superficial (stages Ta and Tis) bladder cancer: a prospective, randomized, stratified study with crossover design.
    Zincke H; Benson RC; Hilton JF; Taylor WF
    J Urol; 1985 Dec; 134(6):1110-4. PubMed ID: 3932685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Long-term results of intravesical prevention of recurrence with mitomycin C and adriamycin in patients with superficial bladder cancer].
    Schwaibold H; Klingenberger HJ; Huland H
    Urologe A; 1994 Nov; 33(6):479-83. PubMed ID: 7817443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Intravesical mitomycin for superficial tumors of the bladder: difficulties of cystoscopic monitoring].
    Fourcade RO; Giuliano F
    Ann Urol (Paris); 1988; 22(6):404-6. PubMed ID: 3146942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravesical doxorubicin for the prophylaxis of superficial bladder tumors. A multicenter study. Blinst Italian Cooperative Group.
    Cancer; 1984 Aug; 54(4):756-61. PubMed ID: 6378357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of mitomycin as prophylaxis following endoscopic resection of superficial bladder cancer.
    Huland H; Otto U
    Urology; 1985 Oct; 26(4 Suppl):32-5. PubMed ID: 4049627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early adjuvant adriamycin in superficial bladder carcinoma.
    Schulman CC; Denis LJ; Costerlinck W; De Sy W; Chantrie M; Bouffioux C; Van Cangh PJ; Van Erps P; De Sloover C
    Prog Clin Biol Res; 1984; 162B():151-62. PubMed ID: 6390444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of intravesical chemotherapy on superficial urinary bladder cancer].
    Moriyama M; Kubota Y; Miura T; Shuin T; Noguchi S
    Hinyokika Kiyo; 1983 Mar; 29(3):351-5. PubMed ID: 6203382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravesical mitomycin C and doxorubicin sequential therapy for carcinoma in situ of the bladder: a longer followup result.
    Sekine H; Fukui I; Yamada T; Ohwada F; Yokokawa M; Ohshima H
    J Urol; 1994 Jan; 151(1):27-30. PubMed ID: 8254827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravesical instillation of mitomycin-C in 242 patients with superficial bladder cancer at high risk of recurrence: long-term results.
    Hurle R; Manzetti A; Losa A; Micheli E; Ranieri A; Chinaglia D; Lembo A
    Urol Int; 1998; 61(4):220-6. PubMed ID: 10364753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Long-term effects on recurrence and mortality in superficial urothelioma of the bladder treated with endovesical chemotherapy].
    Ferraris V; Serao A; Buffa G
    Minerva Urol Nefrol; 1999 Jun; 51(2):95-101. PubMed ID: 10429419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alternating mitomycin C and bacillus Calmette-Guerin instillation prophylaxis for recurrent papillary (stages Ta to T1) superficial bladder cancer. Finnbladder Group.
    Rintala E; Jauhiainen K; Kaasinen E; Nurmi M; Alfthan O
    J Urol; 1996 Jul; 156(1):56-9; discussion 59-60. PubMed ID: 8648837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
    Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylaxis of superficial bladder cancer with mitomycin or interferon alfa-2b: results of a multicentric Italian study.
    Boccardo F; Cannata D; Rubagotti A; Guarneri D; Decensi A; Canobbio L; Curotto A; Martorana G; Pegoraro C; Selvaggi F
    J Clin Oncol; 1994 Jan; 12(1):7-13. PubMed ID: 8270987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer.
    Martínez-Piñeiro JA; Jiménez León J; Martínez-Piñeiro L; Fiter L; Mosteiro JA; Navarro J; García Matres MJ; Cárcamo P
    J Urol; 1990 Mar; 143(3):502-6. PubMed ID: 2106041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Preliminary results of a multicenter study with mitomycin C in superficial bladder tumors (Ta, T1)].
    Allona Moncada A; García Vaquero S; Zuloaga Gómez A; Martínez Torres JL; López-Pardo R; Molina J; Camacho JE; Rodríguez Rubio F; Varo C
    Actas Urol Esp; 1988; 12(5):424-9. PubMed ID: 3146214
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.